Amanda J. McFarlane

CXCR2 inhibition enables NASH-HCC immunotherapy

Jack Leslie, John B. G. Mackey, Thomas Jamieson et al. · Gut · 2022 · 210 citations · Full text

Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans

S. Currie, Emily Gwyer Findlay, Amanda J. McFarlane et al. · The Journal of Immunology · 2016 · 137 citations · Full text

Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota

Amanda J. McFarlane, Henry J. McSorley, Donald J. Davidson et al. · Journal of Allergy and Clinical Immunology · 2017 · 125 citations · Full text

Host Response, Pulmonary Virus Infection, Pathogenesis +8

Respiratory syncytial virus infection influences tight junction integrity

Jeannette I. Kast, Amanda J. McFarlane, Anna Głobińska et al. · Clinical & Experimental Immunology · 2017 · 97 citations · Full text

Asthma, Viral Replication, Healthy Subjects +11

Combination peptide immunotherapy based on <scp>T</scp>‐cell epitope mapping reduces allergen‐specific <scp>I</scp>g<scp>E</scp> and eosinophilia in allergic airway inflammation

Karen J. Mackenzie, Paul M. Fitch, Melanie D. Leech et al. · Immunology · 2012 · 30 citations · Full text

Asthma, Lung Inflammation, Immunology +21